spoon feed

spoon feed

Download on the App Store

spoon feed episodes

  • JAMA PODCAST: Patient Satisfaction With AI-Generated Responses

    How do patients feel about the quality of AI-generated responses to their messages to clinicians?

    Author Eleni Linos, MD, DrPH, of Stanford joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss her recent study in JAMA Network Open that characterized satisfaction with these messages.

    The post JAMA PODCAST: Patient Satisfaction With AI-Generated Responses first appeared on האיגוד הישראלי לרפואה דחופה.

    19 min
  • PODCAST: EM Quick Hits 72 EMC²: Peds Neurocritical Care, Pulmonary Hypertension, Cytokine Release Syndrome, Peds Wrist Fracture, Bradycardia ECG Interpretation, Coaching the EM Mind Part 2
    “This learning material is sourced from Emergency Medicine Cases  and has been published here with permission as per Creative Commons copyright.”
    Topics in this EM Quick Hits podcast

    Amna Karabegovic on a case of pediatric altered LOA and neurocritical care review (2:09)

    Anand Swaminathan on management of pulmonary hypertension and RV failure (24:32)

    Brit Long on cytokine release syndrome (30:44)

    Andrew Tagg on management of pediatric distal radius fractures (39:31)

    Jesse McLaren on ECG interpretation for the bradycardic patient (46:05)

    Sara Gray & Katie Lin on Coaching the EM Mind Part 2: stress management and optimizing safety on shift (52:55)

    Podcast production, editing and sound design by Anton Helman

    Podcast content, written summary & blog post by Sara Brade, edited by Anton Helman, July, 2026

    Cite this podcast as: Helman, A. Lin, K. Karabegovic, A. Swaminathan, A. Long, B. Tagg, A. McLaren, J. Gray, S. EM Quick Hits 72 – EMC²: Peds Neurocritical Care, Pulmonary Hypertension, Cytokine Release Syndrome, Peds Wrist Fracture, Bradycardia ECG Interpretation, Coaching the EM Mind Part 2 Emergency Medicine Cases. July, 2026. https://emergencymedicinecases.com/em-quick-hits-72-july-2026/ ‎. Accessed August 16, 2026.

    EM Cases Cases (EMC²): Pediatric Neurocritical Care
    A previously healthy five-year-old presented with headache, vomiting and a rapidly depressed level of consciousness. CT showed extensive intracranial and intraventricular hemorrhage with hydrocephalus and cerebral edema, ultimately attributed to an arteriovenous malformation. This case highlights the nuances of ED management of the neurocritical pediatric patient.

    Rapid neurologic assessment and differential diagnosis for the altered pediatric patient

    In the crashing child suspected of neurologic catastrophy, focus on the essential neurologic exam: eyes/pupils, verbal response and motor response.

    AVPU—Alert, responds to Voice, responds to Pain, Unresponsive—can provide a fast common language when calculating an exact GCS is impractical, and correlates well with GCS.

    • Organize the differential into structural versus metabolic causes. Check glucose, temperature and vital signs immediately, but maintain a low threshold for urgent head CT when the clinical picture points towards a structural emergency (i.e. headache, vomiting and markedly depressed consciousness).
    • Appropriate CT should not be delayed solely because the patient is a child who is at risk from radiation exposure when the presentation is life-threatening and the result will change immediate management.
    • Immediate management priorities in a child with raised intracranial pressure (ICP)
      • Elevate the head of the bed and keep the neck midline; provide adequate analgesia and antiemetic therapy.
      • Maintain oxygenation, normothermia, euglycemia and euvolemia with isotonic fluid. Avoid hypoxia and hypotension, both of which worsen secondary brain injury.
      • For suspected pediatric intracranial hypertension, 3% hypertonic saline is the preferred first-line hyperosmolar therapy: an easy memory aid is 3% saline at 3 mL/kg IV.
      • Mannitol remains an alternative when hypertonic saline is unavailable, but monitor closely for osmotic diuresis, hypovolemia and electrolyte abnormalities.
      • Pediatric neurocritical airway management considerations
        • Aim for first-pass success with the most experienced available operator, video laryngoscopy, full preoxygenation and a clearly communicated backup plan.
        • Minimize hypoxemia and hemodynamic swings during airway management. Laryngoscopy-related bradycardia in children is often driven by hypoxia; preventing desaturation is more important than routine atropine pretreatment.
        • Have atropine and epinephrine immediately available. Atropine is not routinely required for pediatric RSI, but may be considered in selected infants (age <1 yr) or when significant bradycardia is already present.
        • Use age-specific blood pressure ranges, avoid hypotension and seek pediatric ICU guidance for hypertension. Evidence-based BP targets for spontaneous pediatric ICH remain limited. The priorities are to avoid hypotension and maintain cerebral perfusion while generally avoiding blood pressure above approximately the 95th percentile for the child’s age, sex and size.
        • Expand to view reference list
          Inhaled nitroglycerine for pulmonary hypertension and RV failure

          Patients with acute pulmonary hypertension—from a large pulmonary embolism or decompensated chronic pulmonary arterial hypertension—can deteriorate rapidly when right-ventricular preload falls or RV afterload rises. The immediate goal is to improve oxygenation and ventilation while avoiding interventions that precipitate RV collapse.

          Initial respiratory support of patients with pulmonary hypertension in the ED
          • Correct hypoxemia and hypercarbia because both increase pulmonary vascular resistance. Avoid endotracheal intubation when a reasonable alternative exists. Transition to invasive positive-pressure ventilation can reduce venous return, increase RV afterload and trigger abrupt hemodynamic collapse.
          • Bi-level non-invasive ventilation (BPAP) may improve oxygenation and lower CO2 while preserving some spontaneous negative-pressure breathing. High-flow nasal oxygen is reasonable when hypoxemia is the main issue, but it will not reliably correct substantial hypercarbia.
          • Inhaled nitroglycerine as pulmonary vasodilator in the ED for pulmonary hypertension
            • Inhaled nitric oxide is a classic rapid pulmonary vasodilator, but it may not be immediately available in the ED. Inhaled epoprostenol is another option, although pharmacy preparation and delivery can introduce clinically important delays.
            • A practical bridge is using nebulized nitroglycerin while waiting for inhaled nitric oxide or epoprostenol. Nitroglycerin is rapidly converted into nitric oxide in the lungs. The suggested dose is 5 mg by nebulizer every 5 minutes. Practically, it is difficult to fit 5mg into the nebulizer chamber so our expert suggests filling the chamber with nitroglycerin and increasing flow rate to max. This is an off-label, time-critical strategy that should be aligned with local critical-care, respiratory-therapy and pharmacy protocols.
            • EM Cases Crit Cases 7 – Pulmonary Hypertension – A Fine Balance

              Expand to view reference list

               

              Recognition and management of Cytokine Release Syndrome after CAR T-cell therapy

              Cytokine Release Syndrome (CRS) is a severe systemic inflammatory response caused by a rapid surge of cytokines. It is increasingly encountered after chimeric antigen receptor T-cell therapy and may range from a mild influenza-like illness to shock, hypoxic respiratory failure and multiorgan dysfunction. Other triggers include: monoclonal antibodies, haploidentical donor stem cell transplantation, and nonprotein cancer drugs.

              CAR T-cell therapy uses genetically modified T cells to attack malignant cells and it is used to treat cancers like ALL, CLL, and multiple myeloma. Examples include:

                • Tisagenlecleucel (KYMRIAH)
                • Axicabtagene ciloleucel (YESCARTA)
                • Brexucabtagene autoleucel (TECARTUS)
                • Lisocabtagene maraleucel (BREYANZI)
                • Idecabtagene vicleucel (ABECMA)
                • Ciltacabtagene autoleucel (CARVYKTI)
                • Consider CRS when a patient within two weeks of CAR T-cell therapy has a fever of at least 38°C that is not better explained by another cause, together with constitutional symptoms, hypotension or hypoxia. There is no single diagnostic ED laboratory or imaging test. Evaluate simultaneously for sepsis, tumour lysis syndrome, pulmonary embolism, heart failure and treatment-related organ injury.

                  ED management of CRS

                  • Resuscitate with judicious fluids, supplemental oxygen and vasopressors as required. Provide antipyretics. Evaluate and treat end-organ dysfunction.
                  • Because sepsis may be indistinguishable at presentation, give broad-spectrum antibiotics when the patient is significantly ill or infection remains plausible.
                  • Contact the treating oncologist or cellular-therapy team early, regardless of severity of illness.
                  • Treatment with tocilizumab, an IL-6 receptor antagonist may be considered under specialist guidance.
                  • Severe or refractory CRS may require corticosteroids.
                  • Bottom line: A recent CAR T-cell infusion (within last 2 weeks) plus otherwise unexplained fever, hypotension or hypoxia should immediately raise CRS. Resuscitate, cover possible infection and involve the oncology/cellular-therapy team early—specific therapy is time-sensitive.

                     

                    Expand to view reference list
                    Management of pediatric displaced distal radius fractures: the CRAFFT Trial

                    A completely displaced pediatric wrist looks alarming and traditionally prompts reduction under sedation or general anesthesia, sometimes with fixation. The CRAFFT trial asked whether immediate anatomic correction improves outcomes that matter to children and families—or whether casting alone allows sufficient remodeling.

                    The paper: Perry DC, Zimmermann A, Achten J, et al. Non-surgical casting versus surgical reduction for children with severely displaced distal radial fractures (the CRAFFT Study): a multicentre, randomised, controlled non-inferiority trial and economic evaluation. The Lancet. Published online April 8, 2026.

                    PICO:

                    Population: 750 children aged 4–10 years with severely displaced distal radial fractures across 49 UK hospitals; 44% had completely off-ended fractures. Intervention: casting without purposeful manipulation, general anesthesia or procedural sedation. Comparison: surgical (closed or open) reduction under general anesthesia or conscious sedation, with fixation permitted at the surgeon’s discretion. Primary outcome: parent-reported PROMIS upper-extremity function at three months. The prespecified non-inferiority margin was −2.5 points.

                    Results:

                      • At three months, surgery produced a small functional advantage: adjusted mean difference 1.64 PROMIS points in favour of reduction.
                      • The confidence interval crossed the conservative non-inferiority margin, so casting did not technically demonstrate non-inferiority for the primary analysis.
                      • The observed difference was below the magnitude families considered meaningful enough to justify surgery, and there was no functional difference by six or twelve months.
                      • Early procedural complications—including pressure injury, wound infection, scarring and nerve irritation—occurred mainly in the surgical group. Refracture was slightly more frequent with casting but remained uncommon overall.
                      • Casting saved approximately £1,665 per patient and had a 100% probability of being cost-effective at the UK thresholds studied.
                      • Limitations and application:

                          • Treatment was unblinded and the primary outcome was parent reported, so expectation may have influenced early scores.
                          • The pragmatic design allowed variation in treatment technique and crossover, although this also improves real-world relevance.
                          • The clearest application is to children aged 4–10 years. Results should not be extrapolated automatically to older children approaching skeletal maturity.
                          • The trial does not support cast-first care when there is neurovascular compromise, threatened skin, an open or intra-articular fracture, or another reason for urgent reduction.
                          • Implementation should be collaborative with local orthopedic teams because practice patterns and thresholds for intervention vary.
                          • Bottom line: For most children aged 4–10 years with a severely displaced distal radius fracture, an intact neurovascular exam and no skin threat, a cast-first strategy is a reasonable default—even when the X-ray looks dramatic. Treat the child’s function and safety, not the radiograph alone.

                             

                            Expand to view reference list
                            Bradycardia and the 12-lead ECG: A systematic approach and BRADI mnemonic

                            ACLS is designed to stabilize primary electrical bradyarrhythmias, but many ED patients are bradycardic because of a secondary, reversible process. The rhythm strip tells you what the rate and rhythm are; the history, vital signs and full 12-lead ECG may tell you why.

                            The BRADI mnemonic for reversible causes of bradycardia in the ED

                            B – BRASH syndrome and hyperkalemia: Think renal dysfunction, AV-nodal blockers, shock and hyperkalemia. Hyperkalemic bradycardia may be sinus or junctional and may show PR prolongation, QRS widening, axis change or peaked T waves. Atropine and pacing may fail; treat suspected hyperkalemia promptly, including empiric calcium when the clinical and ECG picture fits.

                            R – Reduced vital signs: Check the complete set: oxygen saturation, glucose and temperature. Hypoxia and hypoglycemia require immediate correction. Hypothermia may produce bradycardia, shivering artifact, prolonged intervals and prominent J waves.

                            A – Acute coronary occlusion: The left circumflex perfuses the SA node as well as the lateral and posterior territories, while the RCA perfuses the SA and AV nodes as well as the inferior and posterior territories. In a patient with ischemic symptoms and bradycardia, look for signs of inferior, lateral or posterior occlusion: inferior ST elevation or hyperacute T waves, reciprocal change in aVL, or anterior ST depression reciprocal to posterior injury.

                            D – Drugs: Consider beta-blockers, calcium-channel blockers, digoxin, opioids and medication accumulation from renal failure. Management may require antidotal or supportive therapy, withholding the culprit drug and allowing clearance. Digoxin may produce a shortened QT interval and scooped ST depression, but most drug causes are identified primarily by history.

                            I – Intracranial pressure (raised) or infection: Raised ICP is primarily a clinical diagnosis, although diffuse deep T-wave inversion and QT prolongation may occur. Lyme carditis may cause high-grade or complete AV block and is a reversible reason to avoid an unnecessary permanent pacemaker.

                            Bottom line: Stabilize the unstable patient, but do not stop at atropine, epinephrine or pacing. Ask why the patient is bradycardic and use the 12-lead ECG most actively when hyperkalemia or acute coronary occlusion is plausible.

                            For examples of the BRADI mnemonic, ECG Cases 58.

                            Coaching the EM Mind Part 2: Stress management and optimizing safety on shift

                            Emergency medicine exposes clinicians to recurring high-stress situations, from critically ill patients and overcrowded departments to challenging interactions with patients, families and colleagues. Stress cannot—and should not—be eliminated entirely. A moderate level of stress can improve energy, focus and performance, while excessive stress can produce panic, cognitive overload and impaired decision-making. The goal is to recognize when stress is moving outside the optimal performance zone and develop practical strategies that can be used before, during and after challenging encounters.

                            Clues to recognizing when stress is becoming excessive for emergency clinicians

                            Clinicians may not immediately recognize that they have entered a state of cognitive or emotional overload. Warning signs include:

                            • Irritability, raising your voice or snapping at others
                            • Difficulty prioritizing patients or making decisions
                            • Feeling unable to absorb one more task or complication
                            • Changes in sleep, nutrition or exercise habits
                            • Withdrawing from activities that are normally enjoyable
                            • Stress from work increasingly affecting home life
                            • Colleagues and family members may recognize these changes before the clinician does. Treat these observations as an opportunity to pause and reassess rather than as criticism.

                              Four strategies for managing stress in the moment during a busy shift or a stressful encounter in the ED
                              1. 1Take a brief break – Even a one- or two-minute pause can improve cognitive bandwidth. Step away when it is safe, drink water, use the bathroom or briefly find a quieter space before returning to the department.
                              2. 2Use controlled breathing – Box breathing is one option. The specific technique matters less than practising it regularly. Breathing exercises become more useful during emergencies when they have already been rehearsed in lower-stress settings.
                              3. Ground yourself physically – Brief grounding exercises redirect attention to the present moment. Examples include intentionally pressing both feet into the floor, noticing the sensation of standing or clasping the hands together. These exercises can be performed discreetly during resuscitations, difficult conversations or other emotionally charged situations.
                              4. Develop positive self-talk – Choose a brief phrase that promotes confidence and focus, such as: “I’ve got this.” “We can do this.” “You can do hard things.” “I am ready.” Positive self-talk can also be directed toward the team: “We are well trained for this. Let’s make a plan.”
                              5. How to prepare yourself and the team before a stressful resuscitation in the ED

                                When time permits:

                                • Walk rather than run to the resuscitation room.
                                • Use controlled breathing on the way.
                                • Repeat your positive self-talk phrase.
                                • Ground yourself physically when you arrive.
                                • Conduct a clear pre-brief and establish a shared plan.
                                • Use calm, confident communication to set the emotional tone
                                • Tools for verbally de-escalating emotionally charged encounters in the ED

                                  The most important principle is to avoid adding more emotion to the interaction.

                                  Practical strategies include:

                                  • Speak slightly slower and more quietly.
                                  • Take an intentional breath and pause before responding.
                                  • Name and validate the emotion: “I can see that you are frustrated.”
                                  • Reorient everyone around a shared goal: “We both want the best outcome for this patient.”
                                  • Use collaborative language such as “we” and “together.”
                                  • Avoid blame, personal attacks and accusatory statements.
                                  • The objective is not necessarily to agree with the other person. It is to lower the emotional temperature enough to return to productive problem-solving.

                                    Speaking up when patient safety is threatened in the ED

                                    Use progressively assertive safety-escalation language:

                                    1. “I notice…”
                                    2. State the objective observation: “I notice the oxygen saturation is 82%.”
                                    3. “I wonder…”
                                    4. Suggest a possible action: “I wonder whether we should apply a non-rebreather mask.”
                                    5. “I’m worried…”
                                    6. Clearly state your concern: “I’m worried that this patient is critically hypoxic.”
                                    7. “This is now a safety concern…”
                                    8. Become direct and declarative when immediate action is required: “This is now a safety concern. We need to address the airway.”

                                      This structure allows concerns to be raised respectfully while ensuring that escalating danger is communicated clearly.

                                      Strategies to recover after a difficult case in the ED

                                      The effects of a stressful resuscitation may continue long after the event is over. Immediate recovery strategies include:

                                      • Conduct a short team debrief.
                                      • Speak with a trusted colleague or friend.
                                      • Take a brief break before seeing the next patient.
                                      • Drink water, eat something or attend to another basic need.
                                      • Seek physical comfort or support when appropriate.
                                      • Arrange a later cold debrief or peer-support follow-up.
                                      • Consider whether continuing the shift is safe.
                                      • Some events—including physical assault or an exceptionally distressing clinical event—may leave a clinician temporarily unable to provide safe care. Departments should have clear processes for obtaining coverage and stepping away when necessary.

                                        Creating transitions between work and home for emergency physicians to improve wellbeing
                                        • At the end of a shift, intentionally recognize three things that went well, even if the shift was otherwise difficult. Use the commute home to decompress through music, a supportive podcast or a conversation with a trusted colleague.
                                        • Before entering the home, take enough time to transition mentally from the clinician role to the role you want to occupy with family and friends.
                                        • A pre-shift routine can provide the opposite transition. Arriving early, listening to educational or motivating material, reviewing why the work matters or using a consistent “walk-on” song can help place the mind into work mode.
                                        • Deep dive on pre-shift strategies: Episode 134 Shift Preparation: Pre-gaming with Rob Orman

                                          How emergency departments can support clinician safety on- and off-shift

                                          Stress management should not be treated solely as an individual responsibility. Emergency departments should consider:

                                          • Regular, interprofessional de-escalation training
                                          • Training clinicians and nurses to lead hot and cold debriefs
                                          • Clear policies following physical or verbal assault
                                          • Processes for obtaining shift coverage after critical events
                                          • Return-to-work support after major incidents
                                          • Accessible and confidential peer-support programs
                                          • Bottom line: Stress-management skills are most useful when they are practised before they are urgently needed. Develop brief techniques through regular practice—breathing, grounding, positive self-talk and safety-escalation language—and use them regularly until they become automatic. Pause, reset and reframe before, during and after stressful encounters. A few deliberate seconds can improve emotional regulation, team communication, clinical performance and safety for both clinicians and patients.

                                            Expand to view reference list
                                            1. Groombridge CJ, Maini A, Ayton D, et al. Emergency physicians’ experience of stress during resuscitation and strategies for mitigating the effects of stress on performance. Emerg Med J. 2022;39(11):839–846. doi:10.1136/emermed-2021-211280.
                                            2. Skutezky T, Small SS, Peddie D, Balka E, Hohl CM. Beliefs and perceptions of patient safety event reporting in a Canadian emergency department: a qualitative study. Can J Emerg Med. 2022;24:867–875. doi:10.1007/s43678-022-00400-2.
                                            3. Richmond JS, Berlin JS, Fishkind AB, et al. Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. West J Emerg Med. 2012;13(1):17–25. doi:10.5811/westjem.2011.9.6864.
                                            4. The post PODCAST: EM Quick Hits 72 EMC²: Peds Neurocritical Care, Pulmonary Hypertension, Cytokine Release Syndrome, Peds Wrist Fracture, Bradycardia ECG Interpretation, Coaching the EM Mind Part 2 first appeared on האיגוד הישראלי לרפואה דחופה.

                                              1 hr 39 min
                                            5. PODCAST: ​Which Is Better? Amiodarone vs. Lidocaine for OHCA

                                              Written by Alex Clark

                                              Spoon Feed

                                              This target trial emulation study showed no statistically significant difference in survival or favorable neurologic outcome between lidocaine and amiodarone in refractory, shockable, out-of-hospital cardiac arrest.

                                              Sparky likes lidocaine

                                              Both amiodarone and lidocaine are guideline-supported therapies for refractory shockable OHCA, but the optimal first-line agent is unclear. Although early trials favored amiodarone, the ROC-ALPS trial found no survival or neurologic benefit for either drug, and more recent observational studies have suggested a possible advantage for lidocaine.

                                              This target trial emulation utilized the Resuscitation Outcomes Consortium Cardiac Epistry to compare lidocaine (n=987) with amiodarone (n=1464) in adults with atraumatic, shockable OHCA refractory to at least three defibrillation attempts. Because the study used cases from 2011–2015, when ACLS guidelines recommended amiodarone as first-line, investigators used inverse probability weighting and doubly robust regression to reduce treatment-selection bias. Lidocaine was associated with higher rates of ROSC at ED arrival (41.0% vs. 34.6%; absolute difference 6.43%; 95%CI 2.6–10.3%) but not with significantly improved survival to hospital discharge (26.2% vs. 23.5%; absolute difference 2.78%; 95%CI–0.6 to 6.2%) or favorable neurologic outcome (17.7% vs. 16.2%; absolute difference 1.5%; 95%CI–1.5 to 4.5%). Although appropriately cautious in their interpretation, the authors suggest the upper bounds of the confidence intervals leave open the possibility for clinically meaningful benefit of lidocaine. While the target trial emulation strengthens causal inference compared to traditional observational analyses, the study still has severe limitations when it comes to drawing any conclusions of superiority, including the older registry data with potentially outdated practices, the inability to assess timing of antiarrhythmic administration, and the potential for residual confounding.

                                              How does this change my practice?

                                              I lean toward amiodarone, partially because that’s what I was trained to use and what the nurses at my institution are most comfortable giving. My practice is to administer an antiarrhythmic early in VF/pVT, probably earlier than many clinicians and certainly earlier than ACLS introduces it. I’m also willing to switch agents later in the resuscitation if still refractory. If a resident wants to start with lidocaine, that is also a reasonable and evidence-based approach, although I will continue reaching for amiodarone first until more definitive evidence emerges. Timing may matter more than which drug is selected, a question this target trial emulation was not designed to address.

                                              Source

                                              Lidocaine versus amiodarone in patients with shockable out-of-hospital cardiac arrest: a target trial emulation. Crit Care Med. 2026 Jul 15. doi: 10.1097/CCM.0000000000007265. Online ahead of print. PMID: 42456091.

                                              The post PODCAST: ​Which Is Better? Amiodarone vs. Lidocaine for OHCA first appeared on האיגוד הישראלי לרפואה דחופה.

                                              4 min
                                            6. PODCAST: You are here: Home / EMCrit / EMCrit 429 – RUSH 2.0 – The I-RUSH and CRUSH Exams EMCrit 429 – RUSH 2.0 – The I-RUSH and CRUSH Exams

                                              July 11, 2026 by Scott Weingart, MD FCCM

                                              The RUSH Exam has grown up. Originally conceptualized in 2006 as a rapid medical surrogate to the trauma FAST exam, the classic protocol was built to find immediate life threats in 30 seconds or less. But hemodynamics in non-crashing patients require more thought and time. Enter RUSH 2.0—the iRUSH (Interface-Informed RUSH) exam.

                                              Inspired by the recent interface model of hemodynamics, this updated protocol transforms the RUSH exam from a tool reserved solely for crashing patients into a standardized bedside map for comprehensive hemodynamic assessment and shock phenotyping.

                                              Huge thanks to Sara Crager for peer review and so many contributions that made this a better work!!!

                                              Prior EMCrit RUSH Posts
                                              • EMCrit 256 – RUSH Redux with Jailyn Avila(Opens in a new browser tab)
                                              • Rapid Ultrasound for Shock and Hypotension – the RUSH Exam(Opens in a new browser tab)
                                              •  

                                                The CRUSH Exam (For Crashing Patients)

                                                If your patient is actively spiraling, you don't have time for complex physiology. You need the CRUSH (Crashing RUSH) exam. This is a hyper-abbreviated screening protocol designed to be executed in under 30 seconds:

                                                • Heart: Parasternal long and apical four-chamber views to assess chamber size and evaluate for effusion/tamponade.
                                                • IVC: Qualitative assessment (big vs. small, collapsing vs. plethoric). No measurements.
                                                • Morrison's in Trendelenburg: A single view focused entirely on the inferior pole of the kidney to rule out large-volume intraperitoneal free fluid.
                                                • Aorta: Four rapid views to rule out an AAA.
                                                • Pulmonary: Two anterior views of the lung to rule out tension pneumothorax.
                                                • The I-RUSH Exam (Interface-Informed RUSH)

                                                  If the patient is not circling the drain, you have time to do a more comprehensive and thoughtful evaluation

                                                  The I-RUSH PDF
                                                  RUSH 2.0 – I-RUSH 
                                                  Images (click on image to enlarge)

                                                  Ultrasound Exams You Need to Know

                                                  EM Resus – Hemodynamic Ultrasound Skills
                                                  Basic

                                                  [] CRUSH Exam

                                                  Essential

                                                  [] LVOT VTI

                                                  [] TAPSE
                                                  [] Qualitative Valvular Assessment
                                                  [] VEXUS (especially portal vein)
                                                  [] Qualitative assessment of Intraventricular Septum
                                                  [] EF Estimation or Measurement
                                                  [] Evaluation of Gross Regional Wall Motion Abnormalities

                                                  Desirable

                                                  [] Measurement of Tricuspid Regurg Jet Peak Velocity (TRV)

                                                   

                                                  Specific Ultrasound Measures
                                                  TRV

                                                  [RVSP=4(TRV)2 +  RAP ] ~ PASP

                                                  Additional Information

                                                  Korbin Haycock writes:

                                                  As long as you've included both TAPSE and Tricuspid regurge velocities, I'd like to point out a few low hanging fruits to add to the raw data points. TAPSE is a decent surrogate of the RV's EF which itself is a rough approximation of RV-PA coupling (interface 4). However, an RV can fail or uncouple from the PA because of different reasons and at different loading conditions. Some examples would be an acute decompensation of chronic PHTN, a PE, or a RV infarct. So when you see a TAPSE that is low, consider it in context of the sPAP and it will give you a good clue as to the mechanism of the uncoupled 4th interface.

                                                  For examples: low TAPSE with sPAP > 65-70 is probalby decompensated prexisting PHTN; low TAPSE with sPAP elevated but < 65 is likely to be a PE; low TAPSE with normal sPAP is a good chance of being a RV infarct. There's some “ins and outs and what have yous” here, but in general the princple holds true.

                                                  Along these lines, in stable PH patients the ratio of TAPSE and sPAP has been shown to be a good surrogate of invasively meausred RV-PA uncoupling, with ratios >0.31 being normal coupling. In acutely decompensated patients I don't think the cut off of 0.31 has been investigated (becuase its probably impossible to conduct such a study), but I have many examples I saved/archived where 4th interface uncoupled patients do have lower TAPSE/sPAP ratios and that when the uncoupling is addressed the ratio dramatically increases.

                                                  A small tip I would give for the Tricuspid regurge measurers out there is you might as well trace a VTI of the TR jet instead of just getting a peak velocity. The reason is it only take a couple more seconds and the machine will spit out at you a peak pressure gradient AND a mean pressure gradient, so you get sPAP and mPAP essentially for free. Doing the TR VTI for a mPAP is additionally useful if you happen to be someone who is doing dPAP (and mPAP) estimates from the PR jet. If the TR VTI mPAP estimate is close to the PR mPAP estimate this is a great validation and cross check that the PR Doppler insonation angle and TR Doppler angles are both pretty good and the estimated values of sPAP, mPAP, and dPAP are thus likely valid.

                                                  Since you have included LVOT VTI in the iRUSH, some may want to push themselves to get a RVOT VTI as well. There are loads and loads of data to be gleaned from a RVOT VTI if you know what to look for, but a submassive/massive PE can be very reliably be recognized from certain RVOT Doppler patterns.

                                                  The post PODCAST: You are here: Home / EMCrit / EMCrit 429 – RUSH 2.0 – The I-RUSH and CRUSH Exams EMCrit 429 – RUSH 2.0 – The I-RUSH and CRUSH Exams first appeared on האיגוד הישראלי לרפואה דחופה.

                                                  30 min
                                                • PODCAST: July 2026 Annals of Emergency Medicine by Annals of Emergency Medicine

                                                  On the July episode of the Annals of Emergency Medicine podcast, Ryan and Rory discuss social vulnerability in EMS recognition, ED social care approaches, pediatric prehospital readiness, and much more.

                                                  The post PODCAST: July 2026 Annals of Emergency Medicine by Annals of Emergency Medicine first appeared on האיגוד הישראלי לרפואה דחופה.

                                                  30 min
                                                • PODCAST: Why Saying "Calm Down" Never Works (and what does)

                                                  When another person is upset or angry, our instinct can be to help them lower their emotional temperature by saying something like, "Just calm down," or, "Relax," or, "Take a breath," or, "Look at the facts." However, saying those things when the other person is in the heat of the moment can have the reverse effect from what we were hoping for.

                                                  The reason is simple: People who do not feel heard are not ready to hear solutions.

                                                  In this episode, we explore the communication strategy of valence matching, why it works at both a psychological and neurological level, and how it can transform interactions with patients, colleagues, consultants, and loved ones. Finally, we show how a few seconds of emotional attunement can save minutes, or even hours, of unnecessary conflict.

                                                  💡 Get Rob's Book

                                                  Supranormal: A Field Guide for the Impossible Job.

                                                  Tools, mindsets, and communication techniques so you don't get eaten alive by a job you're good at.

                                                  The post PODCAST: Why Saying "Calm Down" Never Works (and what does) first appeared on האיגוד הישראלי לרפואה דחופה.

                                                  23 min
                                                • PODCAST: When you go your way, and I Go Mine – Surgery or Antibiotics for Acute Appendicitis.

                                                  Date: June 12, 2026

                                                  Guest Skeptic: Mr. Ross Fisher. Ross is a paediatric surgeon, presentation guru (P-Cubed), and long-time friend of the SGEM.

                                                  Reference: Talan et al. Nonoperative Treatment of Appendicitis and Implications for Emergency Department Management: A Narrative Review. Ann Emerg Med. June 2026

                                                  Case: A 29-year-old healthy man presents to the emergency department (ED) with 18 hours of abdominal pain that began around the umbilicus and migrated to the right lower quadrant. He has anorexia, nausea, a temperature of 38.1°C, and focal right lower quadrant (RLQ) tenderness without diffuse peritonitis. The white blood cell (WBC) count is 13,500/µL. CT abdomen/pelvis shows an 8-mm inflamed appendix with periappendiceal fat stranding but no abscess, phlegmon, perforation, mass, or appendicolith. He is hemodynamically stable, not immunocompromised, has no history of inflammatory bowel disease (IBD), can return to the ED if worse, and asks whether he really needs surgery tonight.

                                                  Background: Appendicitis is one of those diagnoses we don’t want to miss. It’s common, it can be sneaky, and the classic textbook presentation only shows up around half the time. That means labs and scores can help, but they often can’t rule out appendicitis. In 2026, imaging (especially CT scans) is still doing much of the heavy lifting.

                                                  For more than a century, appendicitis was taught as a surgical emergency: diagnose it, call surgery, and remove the appendix before it ruptures. This new narrative review challenges that mental model. It argues that modern imaging can identify uncomplicated appendicitis, that perforated and nonperforated appendicitis may be biologically different entities, and that short delays to surgery in uncomplicated disease do not appear to increase perforation risk. This new narrative review notes that the American College of Surgeons (ACS) has endorsed antibiotics as a safe alternative for selected patients while continuing to endorse appendectomy.

                                                  The SGEM has followed this topic for years, and our interpretation of the literature has evolved as the evidence has changed (see list of other SGEM episodes at the end of this blog post). In 2015, the SGEM emphasized diagnostic uncertainty and concern that failed antibiotics could increase morbidity; in 2017, the pediatric conclusion was that NOTA was “not ready for prime time.” By 2019, we were more open to antibiotics in selected patients, using shared decision-making and acknowledging that nonoperative care may be better than we thought, though it may (or may not) come with a small absolute increase in complications.

                                                  So, the question is no longer whether to cut or not to cut. The ED question is: who is safe for an antibiotic-first pathway, who needs the surgeon now, and who can reliably come back if things go sideways? This is a classic preference-sensitive decision: surgery is highly definitive, while antibiotics may reduce pain, disability, and time away from school or work, but with a meaningful recurrence/appendectomy risk. This review by Talan et al explicitly places emergency physicians in the shared decision-making role for selected uncomplicated appendicitis patients.

                                                  Clinical Question: In ED patients with imaging-confirmed acute uncomplicated appendicitis, can initial nonoperative management with antibiotics and observation, with appendectomy reserved for worsening, nonresponse, or recurrence, be considered a safe and effective alternative to urgent appendectomy?

                                                  This matters because appendicitis sits right at the intersection of emergency medicine, surgery, radiology, antibiotics, patient values, and system capacity. Some patients want the most definitive treatment. Others want to avoid surgery if it’s safe to do so. Our job is not to sell one option. Our job in the emergency department is to explain the trade-offs.

                                                  Reference: Talan et al. Nonoperative Treatment of Appendicitis and Implications for Emergency Department Management: A Narrative Review. Ann Emerg Med. June 2026

                                                  • Population: Adults and children with clinically suspected, localized, imaging-confirmed acute, uncomplicated appendicitis. The included trials enrolled children as young as 5 years and adults older than 80 years.
                                                    • Exclusions: The major exclusions were diffuse peritonitis, severe systemic illness/sepsis, pregnancy, immunocompromise, renal failure, inflammatory bowel disease (IBD), prior antibiotic-treated appendicitis, and imaging evidence of major abscess, phlegmon, perforation, mass, or tumour. Some trials also excluded appendicolith, abnormal WBC thresholds, prolonged pain duration, or older age.
                                                    • Intervention: Nonoperative treatment: initial antibiotics plus observation, with appendectomy if the patient worsened, failed to improve, or later recurred. Antibiotic regimens varied but generally used parenteral antibiotics followed by oral antibiotics to complete a total therapy of 7–10 days.
                                                    • Comparison: Urgent appendectomy with perioperative antibiotics, usually laparoscopic in the more recent trials.
                                                    • Outcome
                                                      • Primary Outcome: There was no single primary outcome in the review. Across the major trials, the most important outcomes were 1-year appendectomy/treatment failure rates for antibiotic-first care, and in CODA, 30-day EQ-5D health-status noninferiority.
                                                      • Secondary Outcomes: Complications/serious adverse events, pain resolution or pain medication use, disability days, recurrence, ED return visits, feasibility of ED discharge/outpatient treatment, cancer detection, cost-effectiveness, and appendicolith subgroup outcomes
                                                      • Type of Study: Narrative review of the major comparative trials, not a true systematic review or meta-analysis.
                                                      • Authors’ Conclusions: “Nonoperative treatment of uncomplicated appendicitis will be increasingly considered as experience and confidence grows among physicians and as awareness grows among patients in this new treatment option. Emergency physicians are being asked about nonoperative treatment of uncomplicated appendicitis and have an important role now to inform patients of their treatment options and expected associated outcomes, and an emerging role in expanding access to safe and cost-effective care for patients with appendicitis, including those who can be managed by nonoperative treatment of uncomplicated appendicitis as outpatients.”

                                                        Quality Checklist for Systematic Reviews: (Yes/No/Unsure)

                                                        1. Was the clinical question sensible and answerable? Yes
                                                        2. Was the search for studies detailed and exhaustive? No
                                                        3. Were the primary studies of high methodological quality? Unsure
                                                        4. Were the assessments of studies reproducible? No
                                                        5. Were the outcomes clinically relevant? Yes
                                                        6. Was there low statistical heterogeneity for the primary outcomes? N/A
                                                        7. Was the treatment effect large enough and precise enough to be clinically significant? Unsure
                                                        8. Who funded the review? The authors stated that no funding was received for this work.
                                                        9. Did the authors declare any conflicts of interest? The authors reported no conflicts of interest.
                                                        10. Results: The review focused on four major comparative trials: APPAC, CODA, MPSC, and APPY. Together, they included more than 2,000 adults and more than 2,000 children. The review did not provide a pooled table of sex, race, baseline pain duration, comorbidities, or socioeconomic demographics.

                                                          Key Result: In selected patients with uncomplicated appendicitis, antibiotics initially worked in about 90% and reduced pain/disability, but roughly one-third underwent appendectomy within 1 year, with higher appendectomy rates among patients with appendicolith.
                                                          • Primary Outcome:
                                                            • APPAC reported a 1-year appendectomy rate of about 27% in adults treated with antibiotics.
                                                            • CODA found antibiotics noninferior to appendectomy for 30-day EQ-5D health status, but the 1-year appendectomy rate was 36% without appendicolith and 52% with appendicolith.
                                                            • MPSC reported a 1-year appendectomy rate of about 33% in children
                                                            • APPY reported about 34% treatment failure/appendectomy in the antibiotic group. The table on page 3 of the review summarizes these trial-specific results.
                                                            • Secondary Outcomes: These generally favoured antibiotics for short-term recovery, but not always for adverse events.
                                                              • APPAC reported fewer 1-year complications with antibiotics than surgery, 2.8% vs 20.5%, with faster pain resolution and fewer disability days.
                                                              • CODA reported similar serious adverse event rates, 3% vs 3%, and fewer disability days with antibiotics.
                                                              • MPSC reported similar complicated appendicitis rates, 3.6% vs 3.3%, and fewer disability days with antibiotics.
                                                              • APPY reported no serious adverse events in either group, but more mild-to-moderate adverse events with antibiotics, largely GI distress; antibiotics reduced post-discharge pain medication use and disability days.
                                                              • The ED discharge data came mainly from CODA. In a CODA sub-analysis, 335 of 726 antibiotic-treated adults, 46%, were discharged from the ED after longer-acting parenteral antibiotics, observation, oral tolerance, stable status, and pain control. Serious adverse events over 7 days were uncommon: 0.9 per 100 outpatients vs 1.3 per 100 inpatients. ED discharge was associated with fewer appendectomies and about one day less disability, without a significant increase in first-week ED return visits.

                                                                Summary of the Four RCTs:

                                                                1. Narrative Review: This was not a systematic review, and that matters. No PRISMA diagram, no duplicate screening, no formal risk-of-bias assessment, and no pooled estimate. That does not make it useless, and we should not judge it against a formal SRMA. It just means we should treat it for what it is, an expert narrative synthesis, not the final word.

                                                                Open Label

                                                                2. Open-Label: The included RCTs were not masked and vulnerable to performance, detection, and preference bias. You really can’t blind antibiotics vs surgery. But when outcomes include pain, disability, and the decision to operate, lack of blinding can push things around. Some failures may have been true clinical deterioration. Others may have been surgeon, patient, or system discomfort with waiting.

                                                                3. Uncomplicated Appendicitis: ED clinicians must exclude abscess, phlegmon, perforation, tumour, diffuse peritonitis, pregnancy, immunocompromise, and other higher-risk conditions. Yet appendicitis diagnosis itself is imperfect: classic symptoms occur in only about half of patients, labs and clinical prediction rules are insufficient to rule in or rule out disease, ultrasound is operator-dependent, and CT can still produce false positives and negative appendectomies. This means the evidence applies best to carefully selected, stable, imaging-confirmed uncomplicated cases, not to all RLQ pain or all appendicitis.

                                                                Heterogeneity

                                                                4. Heterogeneity: The RCTs differed by age group, randomization method, inclusion of appendicolith, antibiotic regimen, inpatient versus outpatient management, thresholds for surgery, primary outcome definitions, and noninferiority margins. A one-year appendectomy rate is not the same as patient-important success if a patient’s goal is avoiding an operation today, reducing pain, minimizing time off work, or avoiding recurrence of anxiety. Without a formal meta-analysis, there is no pooled I², no forest plot, and no systematic exploration of heterogeneity.

                                                                5. Rare & Long-Term Outcomes: These outcomes remain uncertain. Missed appendiceal cancer is uncommon, but the review reports cancer in 5 of 1,033 CODA-qualifying antibiotic-treated adults at 2 years, with a median diagnosis at 3 months and all stage 1. That is reassuring but not definitive for older adults or those with atypical imaging. Pediatric outpatient data remain sparse, and cost-effectiveness depends heavily on the health system, discharge model, return visits, recurrent symptoms, and whether recurrences are treated with antibiotics or surgery. The review is promising for ED pathways, but the evidence is not equally mature for children, patients with appendicolith, older adults, rural sites without surgical backup, or patients with unreliable follow-up.

                                                                Compare the Authors’ Conclusion Compared with the SGEM Conclusion: The authors seem more optimistic about an expanded ED role. They argue that nonoperative treatment is a safe alternative for selected uncomplicated appendicitis patients, that ED discharge/outpatient care is feasible in many adults, and that emergency physicians should be prepared to initiate shared decision-making and outpatient pathways.

                                                                We are more cautious due to the strength of the evidence, diagnostic uncertainty, patient selection, the possibility of increased perforation/complications with failed nonoperative care, and the importance of shared decision-making (SDM).

                                                                SGEM Bottom Line: Antibiotics-first is a reasonable option for carefully selected stable patients with CT-confirmed uncomplicated appendicitis. It is not meant for everyone. Appendectomy is still the definitive treatment, and appendicoliths are a big red flag. It should be shared decision-making, not shared wishful thinking.

                                                                Case Resolution: The patient’s CT shows uncomplicated appendicitis without appendicolith. Surgery is consulted. After discussing appendectomy versus antibiotics, he says avoiding surgery today is very important because he has no paid sick leave, but he is comfortable returning if getting worse. He receives intravenous (IV) ceftriaxone plus metronidazole, analgesia, and antiemetics. After several hours, he is afebrile, pain is improved, he tolerates oral intake, and he remains hemodynamically stable. He is discharged with oral antibiotics to complete a 7- to 10-day total course, written instructions to return immediately if worse, and follow-up within 24 to 48 hours.

                                                                Clinical Application: This review should not make ED clinicians offer antibiotics to every patient with appendicitis. It should prompt EDs to create local pathways with surgery, radiology, pharmacy, and follow-up systems. Candidates should have localized uncomplicated appendicitis, no diffuse peritonitis, no abscess/phlegmon/perforation/tumour, no severe sepsis, no pregnancy, no major immunocompromise, no inflammatory bowel disease, and ideally no appendicolith unless the higher failure risk is explicitly discussed. Outpatient management should be reserved for patients who improve, tolerate oral intake, have controlled pain, can access antibiotics, and can reliably return.

                                                                What Do I Tell the Patient? You have appendicitis, but the CT scan suggests it is the uncomplicated kind. There are two reasonable options. Surgery is the most definitive option. It removes the appendix, so this problem is very unlikely to come back, but it means an operation, anesthesia, incisions, and recovery time. Antibiotics may let you avoid surgery today. In the large studies, most people improved at first, and about 2 out of 3 avoided surgery for at least a year. The trade-off is that about one out of three still needs surgery within a year, and the risk is higher if there is a stone in the appendix. There is not one right answer for everyone. Let’s talk about what matters most to you, and you can decide with the surgery team.

                                                                Keener Kontest: Last week’s winner was our friend, Dr. Steven Stelts from New Zealand. He knew the 2024 international consensus report defines diabetic ketoacidosis (DKA) by the presence of all three of these features:

                                                                • Diabetes or Hyperglycaemia – Blood glucose ≥200 mg/dL (11.1 mmol/L) or a prior history of diabetes
                                                                • Ketosis – Beta-hydroxybutyrate ≥3.0 mmol/L or urine ketones ≥2+
                                                                • Metabolic Acidosis – Venous/arterial pH <7.3 and/or bicarbonate <18 mmol/L
                                                                • Listen to the SGEM podcast for this week’s question. If you know the answer, then send an email to [email protected] with “keener” in the subject line. The first correct answer will receive a shout-out.

                                                                  Other SGEM Episodes:

                                                                  • SGEM #115: Complicated-Non-operative Treatment of Appendicitis (NOTA)
                                                                  • SGEM #180: The First Cut is the Deepest- N.O.T. for Paediatric Appendicitis
                                                                  • SGEM #256: Doctor Doctor Give Me the News, I Gotta Bad Case of RLQ Pain- Should I have an Appendectomy?
                                                                  • SGEM #345: Checking In, Checking Out for Non-Operative Treatment of Appendicitis (APPAC II RCT)
                                                                  • SGEM #384: Take Me Out Tonight, I Don’t Want to Perforate My Appendix Alright
                                                                  • SGEM#476: Cuts like a Knife or Antibiotics for Pediatric Appendicitis
                                                                  • The post PODCAST: When you go your way, and I Go Mine – Surgery or Antibiotics for Acute Appendicitis. first appeared on האיגוד הישראלי לרפואה דחופה.

                                                                    41 min
                                                                  • PODCAST: Face mask ventilation is one of those skills that can easily be overlooked.

                                                                    Face mask ventilation is one of those skills that can easily be overlooked. It's often seen as the simple bit of airway management — something that sits below the glamour of videolaryngoscopy, fibre-optics and endotracheal intubation. But the reality is that excellent face mask ventilation is one of the most important airway skills we have.

                                                                    In this episode, we take a deep dive into bag-valve-mask ventilation and airway adjuncts, exploring why this is far more than just putting a mask on a face and squeezing a bag. We discuss when facemask ventilation is indicated, how to identify patients who may be difficult to ventilate, and the practical steps that can dramatically improve success rates.

                                                                    We cover positioning, airway opening manoeuvres, mask seal techniques, the role of airway adjuncts and how to recognise whether your ventilations are actually working. We also look at troubleshooting common problems, the evidence comparing bag-mask ventilation with supraglottic airways and endotracheal intubation, and how to decide when it's time to move to another airway strategy.

                                                                    Whether you're working in the emergency department, prehospital environment or critical care, this episode is packed with practical tips, cognitive aids and evidence-based advice to help you deliver facemask ventilation with confidence and excellence.

                                                                    Once again we'd love to hear any thoughts or feedback either on the website or via X @TheResusRoom!

                                                                    Simon. Rob & James

                                                                    The post PODCAST: Face mask ventilation is one of those skills that can easily be overlooked. first appeared on האיגוד הישראלי לרפואה דחופה.

                                                                    1 hr
                                                                  • PODCAST: The PE ECG Finding Everyone Memorizes… But Gets Wrong

                                                                    Pulmonary embolism ECG findings are one of the most commonly tested Emergency Medicine board topics — and one of the easiest places to get tricked. Let's quickly cover what is the right answer on boards, and how in real life there is an even better option.

                                                                    The post PODCAST: The PE ECG Finding Everyone Memorizes… But Gets Wrong first appeared on האיגוד הישראלי לרפואה דחופה.

                                                                    11 min
                                                                  • PODCAST: CMS on Boarding

                                                                    Recorded live at the ACEP Leadership and Advocacy Conference, this episode of ACEP Frontline features a timely conversation with Dr. Sean Michael, Chief Medical Officer for Centers for Medicare & Medicaid Services. As emergency departments across the country continue to face unprecedented crowding, prolonged boarding, staffing strain, and access challenges, Dr. Michael joins us to discuss how CMS is viewing the crisis and what potential policy “levers” may help address the growing nationwide problem. From hospital throughput and inpatient capacity to quality measures and accountability, we explore how federal policy could influence meaningful change for patients, physicians, hospitals, and the emergency care system as a whole.

                                                                    The post PODCAST: CMS on Boarding first appeared on האיגוד הישראלי לרפואה דחופה.

                                                                    32 min

                                                                  About spoon feed

                                                                  From the publisher's feed

                                                                  The Israel Association for Emergency Medicine